Left Ventricular Assist Device Thrombosis
نویسندگان
چکیده
منابع مشابه
Left ventricular-assist device arrest: total thrombosis of a continuous flow left ventricular-assist device.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/ehjci/jev290 Online publish-ahead-of-pr...
متن کاملUnexpected abrupt increase in left ventricular assist device thrombosis.
BACKGROUND We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. We investigated the occurrence of pump thrombosis and elevated lactate dehydrogenase (LDH) levels, LDH levels presaging thrombosis (and associated hemolysis), and outc...
متن کاملPlatelet inhibition with ticagrelor for left ventricular assist device thrombosis.
A lthough considered standard therapy for Stage D heart failure since 2008, the continuous, axial flow HeartMate II (HMII) left ventricular assist device (LVAD) has recently been associated with unexpected rise in rates of pump thrombosis. 1 With an incidence of 0.01 to 0.11 events per patient-year, LVAD thrombosis responds to intensification of antithrombotic therapy with unfractionated hepari...
متن کاملThe diagnosis of left ventricular assist device thrombosis
The clinical course of a patient with a left ventricular assist device is described. A total of 6 weeks after device insertion, the lactate dehydrogenase (LDH) level increased to 2801 U/l despite adding low-molecular-weight heparin to acenocoumarol and aspirin. Pump thrombosis was suspected but unconfirmed by computed tomography. Increased pump power requirement did not occur. Instituting unfra...
متن کاملSurgical technique influences HeartMate II left ventricular assist device thrombosis.
BACKGROUND Thrombosis of the HeartMate II (HM2 [Thoratec Corporation, Pleasanton, CA]) is a potentially devastating complication. While attention has been focused on anticoagulation strategies to prevent this complication, the impact of surgical technique has not been assessed. METHODS Patients undergoing HM2 implantation at two institutions were reviewed. Pump thrombosis (PT) was defined as ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Heart Failure
سال: 2015
ISSN: 2213-1779
DOI: 10.1016/j.jchf.2014.12.001